PharmEasy looking to ride the health sector wave is eyeing to acquire listed diagnostics services provider Thyrocare in a Rs 7,000 cr deal as per reports.
Moneycontrol reports as per sources that the API holding's the parent company of PharmEasy is likely to announce the deal ahead of it's planned $1.2 million IPO. PharmEasy is also in the spotlight as Tiger Global and Facebook co-founder Eduardo Saverin’s B Capital has invested $20 million in the medical portal. With this round of fund raising PharmEasy is now valued at $1.8 billion, up from $1.5 billion in April, joining India’s fast-growing pool of unicorns.